An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma

Despite the established role of Ki67 labeling index in prognostic stratification of adrenocortical carcinomas and its recent integration into treatment flow charts, the reproducibility of the assessment method has not been determined. The aim of this study was to investigate interobserver variability among endocrine pathologists using a web-based virtual microscopy approach. Ki67-stained slides of 76 adrenocortical carcinomas were analyzed independently by 14 observers, each according to their method of preference including eyeballing, formal manual counting, and digital image analysis. The interobserver variation was statistically significant (P<0.001) in the absence of any correlation between the various methods. Subsequently, 61 static images were distributed among 15 observers who were instructed to follow a category-based scoring approach. Low levels of interobserver (F=6.99; Fcrit=1.70; P<0.001) as well as intraobserver concordance (n=11; Cohen &kgr; ranging from −0.057 to 0.361) were detected. To improve harmonization of Ki67 analysis, we tested the utility of an open-source Galaxy virtual machine application, namely Automated Selection of Hotspots, in 61 virtual slides. The software-provided Ki67 values were validated by digital image analysis in identical images, displaying a strong correlation of 0.96 (P<0.0001) and dividing the cases into 3 classes (cutoffs of 0%-15%-30% and/or 0%-10%-20%) with significantly different overall survivals (P<0.05). We conclude that current practices in Ki67 scoring assessment vary greatly, and interobserver variation sets particular limitations to its clinical utility, especially around clinically relevant cutoff values. Novel digital microscopy–enabled methods could provide critical aid in reducing variation, increasing reproducibility, and improving reliability in the clinical setting.

[1]  M. Papotti,et al.  Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma , 2014, Modern Pathology.

[2]  Toby C. Cornish,et al.  Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas. , 2013, American journal of clinical pathology.

[3]  A. Tabarin,et al.  Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  T. Giordano The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma. , 2011, The American journal of surgical pathology.

[5]  M. Papotti,et al.  Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. , 2015, The Journal of clinical endocrinology and metabolism.

[6]  A. Zelenetz,et al.  Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  A. Hida,et al.  Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells , 2015, Breast Cancer.

[8]  John M S Bartlett,et al.  An international Ki67 reproducibility study. , 2013, Journal of the National Cancer Institute.

[9]  Harald Frick,et al.  How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists , 2012, PloS one.

[10]  M. Fassnacht,et al.  Update in adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[11]  V. Adsay Ki67 Labeling Index in Neuroendocrine Tumors of the Gastrointestinal and Pancreatobiliary Tract: To Count or Not to Count Is Not the Question, But Rather How to Count , 2012, The American journal of surgical pathology.

[12]  John M S Bartlett,et al.  An international study to increase concordance in Ki67 scoring , 2015, Modern Pathology.

[13]  Anais Malpica,et al.  Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer , 2012, Histopathology.

[14]  T. Miyazaki,et al.  Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility , 2015, Journal of Clinical Pathology.

[15]  Benoît Plancoulaine,et al.  A simple way of quantifying immunostained cell nuclei on the whole histologic section , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[16]  V. Rousson,et al.  IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours , 2006, Histopathology.

[17]  Vilppu J Tuominen,et al.  ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67 , 2010, Breast Cancer Research.

[18]  A. Gill,et al.  Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers. , 2015, The oncologist.

[19]  A. Gill,et al.  Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. , 2009, Endocrine-related cancer.

[20]  N. Kanomata,et al.  Assessment of the Ki67 labeling index: a Japanese validation ring study , 2014, Breast Cancer.

[21]  T. Giordano,et al.  Assessing Biological Aggression in Adrenocortical Neoplasia. , 2014, Surgical pathology clinics.

[22]  Michael Goodman,et al.  Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies , 2015, Modern Pathology.

[23]  Thomas Rüdiger,et al.  Inter‐laboratory and inter‐observer reproducibility of immunohistochemical assessment of the Ki‐67 labelling index in a large multi‐centre trial , 2002, The Journal of pathology.

[24]  Toby C. Cornish,et al.  Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. , 2015, American journal of clinical pathology.

[25]  Martin Fassnacht,et al.  Adrenocortical carcinoma: a clinician's update , 2011, Nature Reviews Endocrinology.

[26]  Marco Saerens,et al.  Clustering methods applied in the detection of Ki67 hot‐spots in whole tumor slide images: An efficient way to characterize heterogeneous tissue‐based biomarkers , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  Andrew P Stubbs,et al.  Automated Selection of Hotspots (ASH): enhanced automated segmentation and adaptive step finding for Ki67 hotspot detection in adrenal cortical cancer , 2014, Diagnostic Pathology.

[28]  G. Baron,et al.  Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors , 2009, Modern Pathology.

[29]  G. Kazemier,et al.  The prognostic value of two different histopathological scoring systems for adrenocortical carcinomas , 2007, Histopathology.

[30]  Jack Cuzick,et al.  Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. , 2011, Journal of the National Cancer Institute.

[31]  H. Tsuda,et al.  Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study , 2013, Cancer science.

[32]  F. Beuschlein,et al.  High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. , 2010, The Journal of clinical endocrinology and metabolism.

[33]  Laura H. Tang,et al.  Objective Quantification of the Ki67 Proliferative Index in Neuroendocrine Tumors of the Gastroenteropancreatic System: A Comparison of Digital Image Analysis With Manual Methods , 2012, The American journal of surgical pathology.

[34]  Laura H. Tang,et al.  Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification , 2011, The American journal of surgical pathology.

[35]  Carsten Denkert,et al.  Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study , 2014, Clinical Cancer Research.

[36]  M. Papotti,et al.  Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates. , 2013, Human pathology.